Literature DB >> 17225717

Radiographic resolution of chronic rhinosinusitis without polyposis after 6 weeks vs 3 weeks of oral antibiotics.

Marc G Dubin1, Frederick A Kuhn, Christopher T Melroy.   

Abstract

BACKGROUND: Maximal medical therapy is poorly defined in chronic sinusitis treatment.
OBJECTIVE: To objectively evaluate the radiographic response of chronic rhinosinusitis without polyposis after 3 and 6 weeks of oral antibiotics.
METHODS: Thirty-five patients with confirmed chronic sinusitis without polyposis (disease apparent on initial computed tomography [CT] with appropriate symptom duration) were prescribed 6 weeks of antibiotics. When possible, culture-directed antibiotics were used; otherwise clindamycin was used empirically. A CT was performed after 3 and 6 weeks of therapy. CTs were then graded by the Lund-Mackay system. Demographic data were reviewed.
RESULTS: Of the 35 patients, 16 underwent all 3 CT scans and completed all 6 weeks of antibiotics. Three patients completed only 3 weeks of antibiotics, and 16 did not undergo the interval 3-week CT. Six patients (38%) had statistically significant improvement in their CT scans between weeks 3 and 6. In this subset of patients who improved, 37% of their overall radiographic improvement occurred in the 3- to 6-week treatment interval. No prognostic variables predicted which patients would radiographically improve after 3 weeks of antibiotics.
CONCLUSION: Some patients achieve radiographic improvement and disease resolution after the completion of a 3-week course of antibiotics. Therefore, maximal medical therapy for chronic sinusitis may consist of longer than 3 weeks of therapy to ensure maximal benefit.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17225717     DOI: 10.1016/S1081-1206(10)60856-3

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  4 in total

1.  [Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; R Weber; K Hörmann
Journal:  HNO       Date:  2012-02       Impact factor: 1.284

2.  Trends in endoscopic sinus surgery rates in the Medicare population.

Authors:  Giridhar Venkatraman; Donald S Likosky; Weiping Zhou; Samuel R G Finlayson; David C Goodman
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-05

Review 3.  Diagnosis and Management of Rhinosinusitis: Highlights from the 2015 Practice Parameter.

Authors:  Kathleen Dass; Anju Tripathi Peters
Journal:  Curr Allergy Asthma Rep       Date:  2016-04       Impact factor: 4.806

4.  The impact of total immunoglobulin E levels on outcomes of maximal medical therapy for chronic rhinosinusitis.

Authors:  Ana M Lemos-Rodriguez; Zainab Farzal; Satyan B Sreenath; Brian D Thorp; Brent A Senior; Adam M Zanation; Charles S Ebert
Journal:  Allergy Rhinol (Providence)       Date:  2017-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.